Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...
GlobalData on MSN6d
Lyndra and Thermo Fisher partner for oral therapiesLyndra secured $101m in Series E financing to advance its pipeline of long-lasting oral therapy products. "Lyndra and Thermo ...
With a market cap of $205.5 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, providing a broad range of products and services across life sciences, analytical ...
Advanced technologies like XRF, OES, and PAT optimize steel production by improving raw material usage, process efficiency, ...
Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...
This important study reveals a new mechanism for gene regulation in neurons by an RNA binding protein called RBM20 previously studied in the heart. The methods used are compelling, including the ...
Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...
Shares of Thermo Fisher Scientific Inc. TMO inched 0.26% higher to $556.99 Tuesday, on what proved to be an all-around ...
We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...
As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink ® Explore Platform to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback